MedTech News
.................... by Andrew Celentano
A Blood Test That Could Detect Breast Cancer as Early as Stage I Has Started Clinical Trials
A new blood test that could lead to earlier detection and treatment of breast cancer.
Study Finds Common Chemicals May Alter Normal Breast Development
Exposure to hormone-disrupting chemicals may leave molecular changes that could someday help identify people at higher risk of breast cancer
AI model decodes the language cells use to communicate
A new computational approach reveals how cells communicate to assemble into tissues. This could accelerate stem cell engineering, improve disease models, and inform therapies.
Centinel Spine gets FDA nod for two-level use of prodisc C Nova
The FDA clearance permits the motion-preserving device to be implanted across two levels in the cervical spine.
How cell type influences the impact of cancer-related protein activity in colorectal cancer
Research has revealed that the role of an important protein in colorectal cancer may vary significantly depending on which cells it is active in. The study, published in the journal npj Precision Oncology, shows that activity of a protein called mTOR may be associated with a stronger immune response in colorectal cancer when it is active in immune cells.
Aortic root enlargement technique allows surgeons to implant heart valves at least two sizes larger
When replacing the aortic valve, a small aortic root can limit the size of the prosthetic valve that can be implanted. If the new valve is too small in relation to the patient’s body, the heart must continue to work against increased resistance—a so-called patient-prosthesis mismatch, which is associated with poorer clinical outcomes.
AI could help predict which HPV infections progress to cancer
For several decades, researchers have sought to identify biomarkers capable of accurately predicting the outcome of an infection with a high-risk oncogenic HPV type. Despite significant advances, no viral, immune-related or molecular marker can currently and reliably predict which infections will regress spontaneously and which will progress to more severe disease.
GE HealthCare’s on-site cyclotron for PET agent production claims CE Mark
GE HealthCare (Nasdaq: GEHC) has claimed a European approval for a relatively compact, self-shielded cyclotron designed for the local production of the rapidly decaying isotopes used in PET imaging tracers.